BMJ Case Reports 2011; doi:10.1136/bcr.07.2010.3181
  • Rare disease

Pseudomyxoma peritonei: disseminated peritoneal adenomucinosis variant

  1. Ashish Kumar Mishra
  1. Department of Surgical Gastroenterology, Chattrapati Shahuji Maharaj University, Lucknow, India
  1. Correspondence to Anshuman Pandey, pananshuman{at}


Pseudomyxoma peritonei (PMP) is a rare disease and even after advances in its understanding and management it often has a protracted course and multiple recurrences despite aggressive surgery and intraperitoneal chemotherapy. The current preferred treatment of ultraradical surgery and hyperthermic intraperitoneal chemotherapy is associated with considerable morbidity and significant mortality. With better understanding we know that the prognosis of the disease is dependent on the degree of total excision of the disease and type of histology. The authors propose the need to be selective in applying aggressive treatment regimens in all patients with PMP regardless of factors like age, low malignant variants and expected morbidities. Our patient had a good outcome with a conservative approach. However, large studies are needed before reaching a conclusion.


  • Competing interests None.

  • Patient consent Obtained.

This article has not yet been cited by other articles.

Register for free content

The full text of all Editor's Choice articles and summaries of every article are free without registration

The full text of Images in ... articles are free to registered users

Only fellows can access the full text of case reports (apart from Editor's Choice) - become a fellow today, or encourage your institution to, so that together we can grow and develop this resource

Don't forget to sign up for content alerts so you keep up to date with all the case reports as they are published, and let us know what you think by commenting on the Editor's blog

Navigate This Article